Capital Research Global Investors’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

Capital Research Global Investors’s Portfolio TRHC Stock Details TRHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-350,340	Closed	-$19.8M	–	431
2019 Q1	$19.8M	Sell	350,340 -375,450	-52%	-$22.4M	0.01%	368
2018 Q4	$46.3M	Sell	725,790 -424,010	-37%	-$30M	0.02%	315
2018 Q3	$93.4M	Sell	1,149,800 -251,000	-18%	-$18.4M	0.03%	293
2018 Q2	$89.4M	Hold	1,400,800	–	–	0.02%	300
2018 Q1	$54.4M	Buy	+1,400,800	New	+$49.1M	0.02%	337

Other funds holding TRHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

NIPH

NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Capital Research Global Investors's TRHC Position: Q2 2019 in Review

Capital Research Global Investors sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q2 2019, closing a stake of 350,340 shares — an estimated $19.8M sold.

Capital Research Global Investors first reported a position in TRHC in Q1 2018 and held it in 5 quarters. The position peaked at $93.4M in Q3 2018. 184 funds tracked by Wall St. Rank hold TRHC as of Q2 2019.

Capital Research Global Investors reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
Capital Research Global Investors sold 350,340 Tabula Rasa HealthCare, Inc. Common Stock shares in Q2 2019, an estimated $19.8M.
Capital Research Global Investors first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q1 2018 and held it in 5 quarters.
Capital Research Global Investors's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $93.4M in Q3 2018.
184 funds tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q2 2019.

Based on Capital Research Global Investors's 13F filing for Q2 2019, filed 14 Aug 2019.